Forgot your password?

Forgot your username?

database > company
Soligenix, Inc
29 Emmons Drive Suite C-10
Princeton, NJ 08540 USA
phone:phone
fax:fax
Click for website
Research Sector
Summary Description
Developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents
Click here for Financial Data
Keywords
Bioterrorism, Oncology,


Description

Soligenix is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain biot......view more

Products / Services

Soligenix, Inc. (Soligenix) (OTCBB: SNGX) is a latestage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal disea......view more


Technology / Differentiation

Soligenix is developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases. Soligenix's lead product, orBec TM (oral beclomethasone dipropionate...view more

Market / Customers

Publicly traded company......view more


Strategy

Stock Snapshot OTC BB: SNGX Recent Stock Price: $0.27 Market Cap: $50 million as of May 31, 2010 Soligenix, Inc. is a late-stage biopharmaceutical company committed to the development of life-sav...view more


Status

Recent Stock Price: $0.27 Market Cap: $50 million as of May 31, 2010 Soligenix, Inc. is a late-stage biopharmaceutical company committed to the development of life-saving therapeutics and vaccin...view more

Analyst Coverage

2 analysts. National and Griffen....view more